Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) was the target of a large drop in short interest during the month of April. As of April 30th, there was short interest totaling 7,692 shares, a drop of 63.5% from the April 15th total of 21,047 shares. Based on an average daily volume of 4,461 shares, the short-interest ratio is currently 1.7 days.
Relief Therapeutics Stock Performance
Shares of OTCMKTS RLFTF remained flat at $0.50 during mid-day trading on Thursday. The company had a trading volume of 2,298 shares, compared to its average volume of 3,475. Relief Therapeutics has a 1-year low of $0.33 and a 1-year high of $4.88. The firm’s 50 day simple moving average is $0.50 and its 200 day simple moving average is $1.81.
About Relief Therapeutics
Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.
The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.
Recommended Stories
- Five stocks we like better than Relief Therapeutics
- The Great SPR Arbitrage: An Oil Market Glitch Fuels Sector Gains
- Why Satellogic Could Be One of the Biggest Space Winners of 2026
- Dividend Growth or High Yield: The Income Investor’s Bet
- A New Focus for GoPro: Is a Takeover in the Frame?
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
